Brief: Sanofi Announces Extension Of Blueprint Tender Offer
17/07/2025 06:03
July 17 (Reuters) - Sanofi SA SASY.PA: EXTENSION OF BLUEPRINT TENDER OFFER OFFER EXPIRATION EXTENDED TO 17:00 EDST, JULY 17, 2025 45.85% OF BLUEPRINT SHARES VALIDLY TENDERED 36.08% OF BLUEPRINT SHARES TENDERED BY GUARANTEED DELIVERY EXTENDS TENDER OFFER FOR BLUEPRINT MEDICINES AT $129 PER SHARE PLUS ONE NON-TRANSFERABLE CONTRACTUAL CONTINGENT RIGHT PER SHARE, REPRESENTING RIGHT TO RECEIVE CONTINGENT PAYMENTS OF UP TO $6.00 PER SHARE IN CASH Source text: ID:nGNE9hSQmT Further company coverage: SASY.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Blueprint Medicines
See all newsBrief: Sanofi Announces Extension Of Blueprint Tender Offer
Brief: Blueprint Medicines Announces Data Reinforcing Safety Profile Of Long-Term Ayvakit
U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle
UBS raises Blueprint Medicines' PT on Sanofi's up to $9.5 billion takeover deal
U.S. RESEARCH ROUNDUP-Biomea Fusion, GE Aerospace, P&G